Orexigen Therapeutics, Inc. (NASDAQ:OREX)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of central nervous system, disorders, with an initial focus on obesity.

Recs

0
Player Avatar jwray01 (99.63) Submitted: 8/15/2012 2:26:07 AM : Underperform Start Price: $4.33 OREX Score: -31.42

stock spam

Featured Broker Partners


Advertisement